Engene Holdings Common Etf Performance
| ENGN Etf | USD 9.53 0.74 7.21% |
The etf shows a Beta (market volatility) of 2.63, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, EnGene Holdings will likely underperform.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in enGene Holdings Common are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, EnGene Holdings displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:1 | Last Split Date 2023-11-01 |
1 | EnGene Encouraged By Promising Response Rates In Bladder Cancer Trial | 11/11/2025 |
2 | Could a Shift in enGene Trial Endpoints Reveal New Priorities in Its Clinical Strategy | 11/13/2025 |
3 | enGene Holdings Inc Surging After Positive Phase 2 LEGEND Trial | 12/05/2025 |
4 | enGene to Release Earnings on Thursday | 12/17/2025 |
5 | enGene Shares Gap Up Heres What Happened | 01/30/2026 |
| Begin Period Cash Flow | 173 M | |
| Total Cashflows From Investing Activities | -25.1 M |
EnGene Holdings Relative Risk vs. Return Landscape
If you would invest 653.00 in enGene Holdings Common on November 4, 2025 and sell it today you would earn a total of 300.00 from holding enGene Holdings Common or generate 45.94% return on investment over 90 days. enGene Holdings Common is currently generating 0.8696% in daily expected returns and assumes 7.7858% risk (volatility on return distribution) over the 90 days horizon. In different words, 69% of etfs are less volatile than EnGene, and 83% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
EnGene Holdings Target Price Odds to finish over Current Price
The tendency of EnGene Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 9.53 | 90 days | 9.53 | about 17.5 |
Based on a normal probability distribution, the odds of EnGene Holdings to move above the current price in 90 days from now is about 17.5 (This enGene Holdings Common probability density function shows the probability of EnGene Etf to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the etf has the beta coefficient of 2.63 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, EnGene Holdings will likely underperform. Additionally EnGene Holdings Common has an alpha of 0.4356, implying that it can generate a 0.44 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). EnGene Holdings Price Density |
| Price |
Predictive Modules for EnGene Holdings
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as enGene Holdings Common. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.EnGene Holdings Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. EnGene Holdings is not an exception. The market had few large corrections towards the EnGene Holdings' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold enGene Holdings Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of EnGene Holdings within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.44 | |
β | Beta against Dow Jones | 2.63 | |
σ | Overall volatility | 1.22 | |
Ir | Information ratio | 0.06 |
EnGene Holdings Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of EnGene Holdings for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for enGene Holdings Common can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| EnGene Holdings is way too risky over 90 days horizon | |
| EnGene Holdings appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (117.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| EnGene Holdings generates negative cash flow from operations | |
| Over 84.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: enGene Shares Gap Up Heres What Happened | |
| The fund retains about 97.03% of its assets under management (AUM) in fixed income securities |
EnGene Holdings Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of EnGene Etf often depends not only on the future outlook of the current and potential EnGene Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. EnGene Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 51.1 M | |
| Cash And Short Term Investments | 193.8 M |
EnGene Holdings Fundamentals Growth
EnGene Etf prices reflect investors' perceptions of the future prospects and financial health of EnGene Holdings, and EnGene Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EnGene Etf performance.
| Return On Equity | -0.53 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 525.99 M | ||||
| Shares Outstanding | 66.98 M | ||||
| Price To Book | 3.81 X | ||||
| EBITDA | (113.8 M) | ||||
| Total Debt | 31.8 M | ||||
| Book Value Per Share | 3.22 X | ||||
| Cash Flow From Operations | (99.24 M) | ||||
| Earnings Per Share | (2.29) X | ||||
| Total Asset | 221.47 M | ||||
| Retained Earnings | (372.03 M) | ||||
About EnGene Holdings Performance
By examining EnGene Holdings' fundamental ratios, stakeholders can obtain critical insights into EnGene Holdings' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that EnGene Holdings is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
EnGene Holdings is entity of United States. It is traded as Etf on NASDAQ exchange.| EnGene Holdings is way too risky over 90 days horizon | |
| EnGene Holdings appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (117.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| EnGene Holdings generates negative cash flow from operations | |
| Over 84.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: enGene Shares Gap Up Heres What Happened | |
| The fund retains about 97.03% of its assets under management (AUM) in fixed income securities |
Other Information on Investing in EnGene Etf
EnGene Holdings financial ratios help investors to determine whether EnGene Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EnGene with respect to the benefits of owning EnGene Holdings security.